Patents Assigned to Biolinq Incorporated
-
Patent number: 11963796Abstract: A skin-adorned physiological or biochemical sensing device is disclosed herein. The device preferably comprises a first substrate and a second substrate. The first substrate comprises an array of solid microneedles designed to penetrate a biological interface to access a physiological fluid or tissue. Each microneedle is capable of electrical interface with the physiological fluid or tissue. The second substrate comprises integrated circuitry designed to transduce at least one signal produced by an electrophysiological or electrochemical reaction. A sensing device is formed that is capable of interpreting the signal arising from the electrophysiological or electrochemical reaction to ascertain the level of some physiological or biochemical entity.Type: GrantFiled: June 16, 2021Date of Patent: April 23, 2024Assignee: Biolinq IncorporatedInventors: Joshua Windmiller, Jared Rylan Tangney
-
Patent number: 11904127Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.Type: GrantFiled: April 25, 2023Date of Patent: February 20, 2024Assignee: Biolinq IncorporatedInventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
-
Patent number: 11872055Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.Type: GrantFiled: October 21, 2022Date of Patent: January 16, 2024Assignee: Biolinq IncorporatedInventors: Jared Rylan Tangney, Joshua Ray Windmiller, Richard Chien Yang
-
Patent number: 11857344Abstract: Fault detection and diagnostics for a microneedle array based continuous analyte monitoring device are provided. The electrochemical sensors, including the electrodes of the analyte monitoring device configured for measuring one or more target analytes, may experience various faults during use of the analyte monitoring device. By modeling the sensors as an electrical network, measurements of the electrical network may be correlated with operational parameters of the sensor. The voltage at the counter electrode provides an indication of the resistance or impedance between the working electrode and the counter electrode and is used to identify the occurrence of faults occurring at the continuous analyte monitoring device.Type: GrantFiled: May 6, 2022Date of Patent: January 2, 2024Assignee: Biolinq IncorporatedInventors: Joshua Ray Windmiller, Alan Steven Campbell, Jared Rylan Tangney
-
Patent number: 11672965Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.Type: GrantFiled: September 27, 2022Date of Patent: June 13, 2023Assignee: Biolinq IncorporatedInventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner
-
Patent number: 11654270Abstract: An applicator for an analyte monitoring device may include an actuatable housing having a body defining a cavity therein and having a distal opening and a side opening. A cuff and a shuttle are received within the cavity and are separately translatable relative to the housing body. A base may removable engage the housing body at the distal opening. The housing body, the cuff, the shuttle, and/or the base may be engaged with one another with one or more releasable coupling features. The base may be removed from an engagement with the housing body, causing the cuff and the shuttle to be aligned and positioned in a configuration in which the analyte monitoring device, held by the shuttle, is ready for insertion into the skin.Type: GrantFiled: September 27, 2022Date of Patent: May 23, 2023Assignee: Biolinq IncorporatedInventors: George Albert Mansfield, III, David Michael Morelock, Mark Christopher Brister, Nathan Thomas Balcom, Joshua David Doan, Joshua Andrew Warner, Paul Daniel Faucher
-
Patent number: 11478194Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.Type: GrantFiled: July 29, 2021Date of Patent: October 25, 2022Assignee: Biolinq IncorporatedInventors: Joshua Ray Windmiller, Jared Rylan Tangney, Buddhadev Paul Chaudhuri, Richard Chien Yang
-
Patent number: 11406818Abstract: A method and device to impart the ability to selectively quantify chemical/biochemical analytes occupying physiological fluids via an automated process that allow the precise and spatially-defined simultaneous deposition of a thin-film of polymer containing an immobilized biorecognition element dispersed therein. A tissue penetrating electrochemical sensor comprises at least one working electrode and at least one of a reference electrode and a counter electrode.Type: GrantFiled: October 28, 2019Date of Patent: August 9, 2022Assignee: Biolinq IncorporatedInventor: Joshua Windmiller
-
Patent number: 10364452Abstract: Methods, systems, and devices are disclosed for providing test strip electrochemical sensors for rapid quantitative analysis of analytes in physiological fluids. In one aspect, an electrochemical sensor includes a substrate; an electrode contingent including a first electrode having a coating of carbon nanotubes (CNTs) and a second electrode on the substrate; and an entrapment layer formed on the first electrode to attach an enzymatic substance capable of causing a redox reaction in the presence of a target analyte of a fluid sample which produces a redox-active product, in which the entrapment layer is structured to include a conductive polymer film that is reversibly dopable to conduct charge carriers across the entrapment layer and at the first electrode. For example, the electrochemical sensor can be provided on a disposable test strip to quantify L-DOPA levels in whole blood, plasma, or serum samples.Type: GrantFiled: June 1, 2015Date of Patent: July 30, 2019Assignees: The Regents of the University of California, Biolinq IncorporatedInventors: Joseph Wang, Irene Litvan, Joshua Ray Windmiller
-
Patent number: D988160Type: GrantFiled: March 16, 2021Date of Patent: June 6, 2023Assignee: Biolinq IncorporatedInventor: David Morelock
-
Patent number: D996999Type: GrantFiled: November 16, 2021Date of Patent: August 29, 2023Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1012744Type: GrantFiled: May 16, 2022Date of Patent: January 30, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock
-
Patent number: D1013544Type: GrantFiled: April 29, 2022Date of Patent: February 6, 2024Assignee: Biolinq IncorporatedInventor: David Michael Morelock